Point72 Asset Management's 6.7% Stake in Pliant Therapeutics, Inc.

Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen have jointly filed a Schedule 13G with the SEC, disclosing a 6.7% ownership stake in Pliant Therapeutics, Inc. The filing indicates that Point72 Asset Management maintains investment and voting power over the shares held by Point72 Associates, LLC, an investment fund it manages. Point72 Capital Advisors, Inc. is the general partner of Point72 Asset Management, and Steven A. Cohen controls both entities. The shares reported are held by Point72 Associates, and the filing is made pursuant to Rule 13d-1(c) of the Securities Exchange Act of 1934. The filing also includes a Joint Filing Agreement, confirming that the statement is filed on behalf of all three entities.